BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 2971602)

  • 1. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathological association between Down syndrome and Alzheimer disease.
    Mann DM
    Mech Ageing Dev; 1988 May; 43(2):99-136. PubMed ID: 2969441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease in Down's syndrome. A review.
    Karlinsky H
    J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
    Mann DM; Yates PO; Marcyniuk B
    Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
    Golaz J; Charnay Y; Vallet P; Bouras C
    Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological studies on senile plaques in brains of patients with Down's syndrome.
    Fukuoka Y; Fujita T; Ito H
    Kobe J Med Sci; 1990 Dec; 36(5-6):153-71. PubMed ID: 1708000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down's syndrome and Alzheimer's disease: a review.
    Oliver C; Holland AJ
    Psychol Med; 1986 May; 16(2):307-22. PubMed ID: 2941815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminar distribution of neuritic plaques in normal aging, Alzheimer's disease and Down's syndrome.
    Rafalowska J; Barcikowska M; Wen GY; Wisniewski HM
    Acta Neuropathol; 1988; 77(1):21-5. PubMed ID: 2977047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Sci; 1985 Jul; 69(3):139-59. PubMed ID: 3162000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic study and chromosome abnormalities of Alzheimer's disease and Down's syndrome].
    Asaka A
    Nihon Rinsho; 1988 Jul; 46(7):1502-7. PubMed ID: 2975715
    [No Abstract]   [Full Text] [Related]  

  • 19. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
    Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease, Down's syndrome, and chromosome 21.
    Lancet; 1987 May; 1(8540):1011-2. PubMed ID: 2883347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.